Current alternative therapies for treating drug-resistant Neisseria gonorrhoeae causing ophthalmia neonatorum

Area of Science:

• Microbiology and Ophthalmology
• Neonatal Infectious Diseases

Background:

• Ophthalmia neonatorum is a serious microbial eye infection in newborns.
• Neisseria gonorrhoeae and Chlamydia trachomatis are primary bacterial culprits acquired during birth.
• Antibiotic resistance in N. gonorrhoeae poses a significant therapeutic challenge.

Purpose of the Study:

• To review alternative therapeutic strategies against N. gonorrhoeae-mediated ophthalmia neonatorum.
• To identify cost-effective treatments that circumvent emerging antibiotic resistance.
• To highlight novel agents for prophylaxis and treatment of neonatal ocular infections.

Main Methods:

• Literature review of antimicrobial agents and formulations.
• Analysis of current therapeutic options and their limitations.
• Exploration of emerging treatments including fatty acids, peptides, and nano-formulations.

Main Results:

• N. gonorrhoeae demonstrates alarming resistance to conventional antibiotics.
• Alternative therapies show promise in combating resistant strains.
• Novel agents like antimicrobial fatty acids, peptides, and nano-formulations are effective against N. gonorrhoeae.

Conclusions:

• Alternative therapies are crucial for managing antibiotic-resistant N. gonorrhoeae in ophthalmia neonatorum.
• Developing novel, cost-effective treatments is imperative to prevent neonatal blindness.
• Antimicrobial fatty acids, peptides, and nano-formulations represent promising avenues for future treatment strategies.